These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 795112)

  • 1. The immunodepressive and hematotoxic activity of imidazole-4-carboxamide,5-(3,3-dimethyl-1-triazeno) in mice.
    Vecchi A; Fioretti MC; Mantovani A; Barzi A; Spreafico F
    Transplantation; 1976 Dec; 22(6):619-24. PubMed ID: 795112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug induced modulation of immune responses in mice: effects of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) and cyclophosphamide (Cy).
    Giampietri A; Bonmassar E; Goldin A
    J Immunopharmacol; 1978-1979; 1(1):61-86. PubMed ID: 401314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term depression of two primary immune responses induced by a single dose of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC).
    Puccetti P; Giampietri A; Fioretti MC
    Experientia; 1978 Jun; 34(6):799-800. PubMed ID: 658308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Depression of the immune response to lymphoma allotransplant with the use of 5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboxamide (DTIC)].
    Giampietri A; Puccetti P; Circolo A; Menconi E
    Boll Soc Ital Biol Sper; 1977 Jun; 53(11):922-6. PubMed ID: 597414
    [No Abstract]   [Full Text] [Related]  

  • 5. Transplantation resistance of drug-treated hybrid or allogeneic mice against murine lymphomas. I. Immunopharmacology studies.
    Bonmassar A; Riccardi C; Rivosecchi-Merletti P; Goldin A; Bonmassar E
    Int J Cancer; 1980 Dec; 26(6):819-29. PubMed ID: 6971268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells.
    Campanile F; Iorio AM; Bonmassar E
    Int J Immunopharmacol; 1984; 6(4):251-8. PubMed ID: 6480192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.
    Giampietri A; Bonmassar A; Puccetti P; Circolo A; Goldin A; Bonmassar E
    Cancer Res; 1981 Feb; 41(2):681-7. PubMed ID: 7448813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.
    Beal DD; Skibba JL; Whitnable KK; Bryan GT
    Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential graft resistance of C3H mice pretreated with antitumor drugs against BALB/c bone marrow or lymphoma cells.
    Campanile F; Bonmassar E
    J Immunopharmacol; 1980; 2(4):527-42. PubMed ID: 7009759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.
    Romani L; Fioretti MC; Bonmassar E
    Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas.
    Testorelli C; Franco P; Goldin A; Nicolin A
    Cancer Res; 1978 Mar; 38(3):830-4. PubMed ID: 75062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and rejection patterns of murine lymphoma cells antigenically altered following drug treatment in vivo.
    Riccardi C; Fioretti MC; Giampietri A; Puccetti P; Goldin A
    Transplantation; 1978 Feb; 25(2):63-8. PubMed ID: 146282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.
    Nardelli B; Puccetti P; Romani L; Sava G; Bonmassar E; Fioretti MC
    Cancer Immunol Immunother; 1984; 17(3):213-7. PubMed ID: 6566603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
    Earl RA; Townsend LB
    J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Mitri E; Cherubino R
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724).
    Houchens DP; Iorio A; Barzi A; Goldin A; Bonmassar E
    Cancer Chemother Rep; 1975; 59(5):967-73. PubMed ID: 1203899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Mizuno NS; Decker RW; Zakis B
    Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe myelosuppression from piperazinedione, (NSC No. 135758), cyclophosphamide plus dimethyl-triazeno-imidazole carboxamide (DTIC).
    Presant CA; Klahr C
    Cancer; 1977 Oct; 40(4):1386-9. PubMed ID: 907959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
    Sava G; Giraldi T; Perissin L; Zorzet S; Mallardi F; Grill V
    Tumori; 1984 Dec; 70(6):477-83. PubMed ID: 6531789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide [NSC 45388, DTIC] on neuroblastoma cells in culture.
    Culver B; Sahu SK; Vernadakis A; Prasad KN
    Biochem Biophys Res Commun; 1977 Jun; 76(3):778-83. PubMed ID: 20080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.